<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04109846</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-46420</org_study_id>
    <nct_id>NCT04109846</nct_id>
  </id_info>
  <brief_title>Pregnancy and Developmental Outcomes After Transfer of Reportedly Aneuploid or Mosaic Embryos</brief_title>
  <acronym>TAME</acronym>
  <official_title>Transfer of Aneuploid or Mosaic Embryos Following Preimplantation Genetic Testing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine how often embryos reported to be abnormal by preimplantation genetic testing
      result in liveborn infants. To evaluate whether the pregnancies that result from these
      embryos are higher risk for complications and whether the resulting babies have higher risk
      for health or developmental issues in the first five years after birth.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 11, 2019</start_date>
  <completion_date type="Anticipated">April 1, 2029</completion_date>
  <primary_completion_date type="Anticipated">April 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patients desiring frozen embryo transfer or aneuploid or mosaic embryo. Patients will be counseled regarding risks and obstetric and pediatric outcomes will be collected.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pregnancy Rate</measure>
    <time_frame>3 years</time_frame>
    <description>Number participants who undergo embryo transfers that lead to a positive pregnancy test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Live birth rate</measure>
    <time_frame>4 years</time_frame>
    <description>Number participants who conceive after embryo transfer and have a live birth.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Obstetric complications</measure>
    <time_frame>4 years</time_frame>
    <description>Number of participants who have a maternal of fetal complication after embryo transfer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pediatric Development</measure>
    <time_frame>7 years 3 months</time_frame>
    <description>Number of newborns and children who have abnormal pediatric development at 3 months, 2 years and 5 years following birth</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Aneuploidy</condition>
  <condition>Mosaicism</condition>
  <arm_group>
    <arm_group_label>Non-euploid Transfer</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients desiring pregnancy who have no acceptable euploid embryos available for transfer who chose to undergo embryo transfer of a non-euploid embryo (either aneuploid or mosaic).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Euploid Transfer</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients desiring pregnancy who are undergoing euploid embryo transfer</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Non-euploid embryo transfer</intervention_name>
    <description>Other than choice of embryo for transfer, all other medical interventions will be at discretion of treating provider</description>
    <arm_group_label>Non-euploid Transfer</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Euploid Transfer</intervention_name>
    <description>Standard of Care Protocol</description>
    <arm_group_label>Euploid Transfer</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Available aneuploid or mosaic embryos

          -  No acceptable euploid embryos available

          -  Willing to travel to Stanford for treatment

          -  English language fluency

        Exclusion Criteria:

          -  Use of gestational carrier

          -  Living outside the United States
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ruth Lathi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alleigh Boyd, MS</last_name>
    <phone>(408)688-9749</phone>
    <email>aboyd@stanfordchildrens.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Stanford Fertility and Reproductive Medicine Center</name>
      <address>
        <city>Sunnyvale</city>
        <state>California</state>
        <zip>94087</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alleigh Boyd, MS</last_name>
      <phone>408-688-9749</phone>
      <email>aboyd@stanfordchildrens.org</email>
    </contact>
    <contact_backup>
      <last_name>Ruth Lathi, MD</last_name>
      <phone>650-498-7911</phone>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.stanfordchildrens.org/en/service/fertility-and-reproductive-health/tame</url>
    <description>Stanford Fertility Website</description>
  </link>
  <reference>
    <citation>Munné S, Spinella F, Grifo J, Zhang J, Beltran MP, Fragouli E, Fiorentino F. Clinical outcomes after the transfer of blastocysts characterized as mosaic by high resolution Next Generation Sequencing- further insights. Eur J Med Genet. 2020 Feb;63(2):103741. doi: 10.1016/j.ejmg.2019.103741. Epub 2019 Aug 21.</citation>
    <PMID>31445143</PMID>
  </reference>
  <reference>
    <citation>Victor AR, Tyndall JC, Brake AJ, Lepkowsky LT, Murphy AE, Griffin DK, McCoy RC, Barnes FL, Zouves CG, Viotti M. One hundred mosaic embryos transferred prospectively in a single clinic: exploring when and why they result in healthy pregnancies. Fertil Steril. 2019 Feb;111(2):280-293. doi: 10.1016/j.fertnstert.2018.10.019.</citation>
    <PMID>30691630</PMID>
  </reference>
  <reference>
    <citation>Zhang L, Wei D, Zhu Y, Gao Y, Yan J, Chen ZJ. Rates of live birth after mosaic embryo transfer compared with euploid embryo transfer. J Assist Reprod Genet. 2019 Jan;36(1):165-172. doi: 10.1007/s10815-018-1322-2. Epub 2018 Sep 24.</citation>
    <PMID>30246223</PMID>
  </reference>
  <reference>
    <citation>Munné S, Blazek J, Large M, Martinez-Ortiz PA, Nisson H, Liu E, Tarozzi N, Borini A, Becker A, Zhang J, Maxwell S, Grifo J, Babariya D, Wells D, Fragouli E. Detailed investigation into the cytogenetic constitution and pregnancy outcome of replacing mosaic blastocysts detected with the use of high-resolution next-generation sequencing. Fertil Steril. 2017 Jul;108(1):62-71.e8. doi: 10.1016/j.fertnstert.2017.05.002. Epub 2017 Jun 1.</citation>
    <PMID>28579407</PMID>
  </reference>
  <reference>
    <citation>Greco E, Minasi MG, Fiorentino F. Healthy Babies after Intrauterine Transfer of Mosaic Aneuploid Blastocysts. N Engl J Med. 2015 Nov 19;373(21):2089-90. doi: 10.1056/NEJMc1500421.</citation>
    <PMID>26581010</PMID>
  </reference>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 24, 2019</study_first_submitted>
  <study_first_submitted_qc>September 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 30, 2019</study_first_posted>
  <last_update_submitted>September 27, 2019</last_update_submitted>
  <last_update_submitted_qc>September 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Ruth Bunker Lathi</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Preimplantation Genetic Testing for Aneuploidy</keyword>
  <keyword>Preimplantation Genetic Screening</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneuploidy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Data will only reported in aggregate</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

